Similar articles

• [Anti HCV in hemodialyzed patients: reduction of the prevalence and association with epidemiological variables].

  Padrone M, Corallini O, Cocozzella D, Malca M, Borzi S, Barrio M, Adrover RE, Cuffini AM, Gomez C, Giamona AM, Brawlasky G, Newmann P, Dell Amo M, Fraquelli E, Curciarello JO. Padrone M, et al. Acta Gastroenterol Latinoam. 1999;29(3):91-4. Acta Gastroenterol Latinoam. 1999. PMID: 10533653 Spanish.
• [Prevalence of anti hepatitis C antibodies in patients with chronic renal failure receiving conservative therapy].

  de Los Ríos R, Bussalleu A, Hurtado A, Valdivia J, Huerta Mercado J, Battilana C, Pala M, Pinto JL, Piscoya A, Cedrón H. de Los Ríos R, et al. Rev Gastroenterol Peru. 2006 Jul-Sep;26(3):265-70. Rev Gastroenterol Peru. 2006. PMID: 17053822 Spanish.
• Prevalence and epidemiology of hepatitis C infection in patients on peritoneal dialysis in France. French PD centers.

  Durand PY, Chanliau J, Gamberoni J, Hestin D, Kessler M. Durand PY, et al. Adv Perit Dial. 1996;12:167-70. Adv Perit Dial. 1996. PMID: 8865894
• Hepatitis C virus infection and the dialysis patient.

  Fabrizi F, Lunghi G, Ganeshan SV, Martin P, Messa P. Fabrizi F, et al. Semin Dial. 2007 Sep-Oct;20(5):416-22. doi: 10.1111/j.1525-139X.2007.00311.x. Semin Dial. 2007. PMID: 17897248 Review.
• [Alcoholic liver injuries].

  Tanikawa K. Tanikawa K. Nihon Rinsho. 1997 Feb;55 Suppl:153-7. Nihon Rinsho. 1997. PMID: 9078726 Review. Japanese. No abstract available.